Affimed (AFMD) Tops Q3 EPS by 6c

Affimed (NASDAQ: AFMD) reported Q3 EPS of (EUR0.11), EUR0.06 better than the analyst estimate of (EUR0.17). Revenue for the quarter came in at EUR14.9 million versus the consensus estimate of EUR6.4 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79